Sanofi looks to sell EU research sites to Covance
Sanofi Aventis intends to sell two of its European research facilities to US-based contract research organisation (CRO) Covance.
Sanofi Aventis intends to sell two of its European research facilities to US-based contract research organisation (CRO) Covance.
Sandoz is conducting a UK patient level recall of certain batches of Temozolomide capsules after they were found to be splitting and leaking powder.
Prosonix has entered into an agreement with Trimel Biopharma, in which both companies will combine their respective technologies to deliver improved inhalation performance for respiratory medicines.
Merck & Co is to close or sell eight manufacturing plants and a further eight R&D laboratories as part of efforts to cuts its workforce by 15 per cent.
reMYND NV is to offer the A4 amyloid testing service to support preclinical screening of Alzheimer’s treatments after inking a deal with Amorfix Life Sciences.
CMO NextPharma has increased its hormone production capacity with an expansion at its facility in Waltrop, Germany.
A new study believes vaccine manufacturers from developing countries may be able to produce a HPV vaccine at a lower cost without infringing on the numerous patents drug makers have taken out on the vaccine technology.